Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck
- 31 March 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (2-3), 484-485
- https://doi.org/10.1016/s0959-8049(05)80083-8
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Head and neck cancer: Prognostic factors for response to chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1991
- Phase II clinical trial of 4′-O-Tetrahydropyranyl-Adriamycin (THP-Adriamycin) in recurrent squamous cell carcinoma of the head and neckInvestigational New Drugs, 1991
- Phase-II-Studie mit Pirarubicin bei vorbehandelten progredienten Kopf-Hals-MalignomenLaryngo-Rhino-Otologie, 1990
- Clinical Experience with Pirarubicin in the Treatment of Patients with Pretreated Head and Neck CancerPublished by S. Karger AG ,1989
- Efficacy of (2"R)-4'-0-tetrahydropyranyl adriamycin (THP) in head and neck malignant tumors.Practica Oto-Rhino-Laryngologica, 1987
- Reporting results of cancer treatmentCancer, 1981
- Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy.The Journal of Antibiotics, 1979
- Tetrahydropyranyl derivatives of daunomycin and adriamycin.The Journal of Antibiotics, 1979